Immune modulating therapy in gastrointestinal cancer.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000627:therapeutic use; D002276:Carcinoid Tumor / Q000188:drug therapy; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D003110:Colonic Neoplasms / Q000628:therapy; D005770:Gastrointestinal Neoplasms / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007372:Interferons / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D008113:Liver Neoplasms; D008213:Lymphocyte Activation; D011425:Propionibacterium acnes / Q000276:immunology; D012004:Rectal Neoplasms / Q000628:therapy
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D001500:BCG Vaccine; D001428:Bacterial Vaccines; D007978:Levamisole; D007372:Interferons